Literature DB >> 25977905

Primary diffuse leptomeningeal gliosarcomatosis.

Ju Hyung Moon1, Se Hoon Kim2, Eui Hyun Kim3, Seok-Gu Kang3, Jong Hee Chang3.   

Abstract

Primary diffuse leptomeningeal gliomatosis (PDLG) is a rare condition with a fatal outcome, characterized by diffuse infiltration of the leptomeninges by neoplastic glial cells without evidence of primary tumor in the brain or spinal cord parenchyma. In particular, PDLG histologically diagnosed as gliosarcoma is extremely rare, with only 2 cases reported to date. We report a case of primary diffuse leptomeningeal gliosarcomatosis. A 68-year-old man presented with fever, chilling, headache, and a brief episode of mental deterioration. Initial T1-weighted post-contrast brain magnetic resonance imaging (MRI) showed diffuse leptomeningeal enhancement without a definite intraparenchymal lesion. Based on clinical and imaging findings, antiviral treatment was initiated. Despite the treatment, the patient's neurologic symptoms and mental status progressively deteriorated and follow-up MRI showed rapid progression of the disease. A meningeal biopsy revealed gliosarcoma and was conclusive for the diagnosis of primary diffuse leptomeningeal gliosarcomatosis. We suggest the inclusion of PDLG in the potential differential diagnosis of patients who present with nonspecific neurologic symptoms in the presence of leptomeningeal involvement on MRI.

Entities:  

Keywords:  Glioma, gliosarcoma; Leptomeningeal carcinomatosis; Meningoencephalitis

Year:  2015        PMID: 25977905      PMCID: PMC4426275          DOI: 10.14791/btrt.2015.3.1.34

Source DB:  PubMed          Journal:  Brain Tumor Res Treat        ISSN: 2288-2405


  10 in total

1.  Heterotopic glial nests in the subarachnoid space; histopathologic characteristics, mode of origin and relation to meningeal gliomas.

Authors:  I S COOPER; J W KERNOHAN
Journal:  J Neuropathol Exp Neurol       Date:  1951-01       Impact factor: 3.685

2.  A report of the natural history of leptomeningeal gliomatosis.

Authors:  T Keith; R Llewellyn; M Harvie; F Roncaroli; M W Weatherall
Journal:  J Clin Neurosci       Date:  2011-04       Impact factor: 1.961

3.  Case of primary diffuse leptomeningeal gliomatosis.

Authors:  Kouji Yamasaki; Kiyotaka Yokogami; Hajime Ohta; Shinji Yamashita; Hisao Uehara; Yuichiro Sato; Hideo Takeshima
Journal:  Brain Tumor Pathol       Date:  2014-01-29       Impact factor: 3.298

4.  Primary diffuse leptomeningeal gliosarcomatosis with a sphenoid/sellar mass: confirmation of the ectopic glial tissue theory?

Authors:  James Dimou; Alpha Tsui; Nicholas F Maartens; James A J King
Journal:  J Clin Neurosci       Date:  2011-02-26       Impact factor: 1.961

5.  Solitary primary leptomeningeal glioma: case report.

Authors:  Young Goo Kim; Eui Hyun Kim; Se Hoon Kim; Jong Hee Chang
Journal:  Brain Tumor Res Treat       Date:  2013-04-30

6.  Primary diffuse leptomeningeal gliomatosis mimicking meningeal tuberculosis.

Authors:  Gerardo Ruiz-Ares; Elena Collantes-Bellido; Francisco Rodriguez de Rivera; Josmarlin Medina-Báez; Farnando Palomo-Ferrer; Carmen Morales-Bastos; Javier Arpa
Journal:  Neurologist       Date:  2011-05       Impact factor: 1.398

Review 7.  Primary diffuse multinodular leptomeningeal gliomatosis: case report and review of the literature.

Authors:  Bertrand Debono; Stéphane Derrey; Charles Rabehenoina; François Proust; Pierre Freger; Annie Laquerrière
Journal:  Surg Neurol       Date:  2006-03

8.  Primary diffuse leptomeningeal gliomatosis mimicking a chronic inflammatory meningitis.

Authors:  Melissa W Ko; Peter E Turkeltaub; Edward B Lee; Nicholas K Gonatas; Nicholas J Volpe; Mark L Moster; Steven L Galetta
Journal:  J Neurol Sci       Date:  2009-01-08       Impact factor: 3.181

Review 9.  Glioblastoma.

Authors:  C Ryan Miller; Arie Perry
Journal:  Arch Pathol Lab Med       Date:  2007-03       Impact factor: 5.534

10.  Primary diffuse leptomeningeal gliosarcomatosis.

Authors:  Yosuke Watanabe; Takuhiro Hotta; Hiroyuki Yoshioka; Yoko Itou; Kiyomi Taniyama; Kazuhiko Sugiyama
Journal:  J Neurooncol       Date:  2007-07-13       Impact factor: 4.506

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.